Noticias y vídeos - ALLERGAN PLC - Página 2

HBK Investments LP - Form 8.3 - Allergan Plc PR Newswire London, May 11 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) HBK Investments L.P. on behalf of itself, its subadvisors and its managed funds Company dealt in ALLERGAN PLC Class of relevant security to which the dealings being disclosed...

Norges Bank - Form 8.3 - Allergan Plc PR Newswire London, May 11 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Norges Bank Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock IE00BY9D5467 Date of dealing 08/05/2020 2....

Pentwater Capital Management LP - Form 8.3 - Allergan Plc PR Newswire London, May 8 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...

Pentwater Capital Management LP - Form 8.3 - Allergan Plc PR Newswire London, May 7 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...

The Allergan Foundation Doubles its COVID-19 Response Donations to $4.0 Million - Total 2020 Charitable Grants to Date Approach $17 Million - - Lifetime Giving Approaches $112 Million - PR Newswire DUBLIN, May 7, 2020 DUBLIN , May 7, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that The Allergan Foundation has fast-tracked another $2 million dollars in charitable grants for community organizations responding to the COVID-19 pandemic. The new grants double The Allergan...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Davidson Kempner Capital Management LP Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 2020-05-05 INTERESTS AND SHORT POSITIONS Interests and...

Pentwater Capital Management LP - Form 8.3 - Allergan Plc PR Newswire London, May 6 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...

Norges Bank - Form 8.3 - Allergan PLC PR Newswire London, May 6 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Norges Bank Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock IE00BY9D5467 Date of dealing 05/05/2020 2....

Announcement relating to the outcome of the Court Sanction Hearing PR Newswire DUBLIN, May 6, 2020 DUBLIN , May 6, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) (" Allergan ") today announced that the High Court of Ireland (the " Court ") has approved the previously announced proposed acquisition...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Davidson Kempner Capital Management LP Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 2020-05-04 INTERESTS AND SHORT POSITIONS Interests and...

Norges Bank - Form 8.3 - Allergan PLC PR Newswire London, May 4 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Norges Bank Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock IE00BY9D5467 Date of dealing 01/05/2020 2....

Pentwater Capital Management LP - Form 8.3 - Allergan Plc PR Newswire London, May 4 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Davidson Kempner Capital Management LP Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 2020-04-30 INTERESTS AND SHORT POSITIONS Interests and...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Davidson Kempner Capital Management LP Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 2020-04-29 INTERESTS AND SHORT POSITIONS Interests and...

Norges Bank - Form 8.3 - Allergan PLC PR Newswire London, April 29 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Norges Bank Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock IE00BY9D5467 Date of dealing 28/04/2020 2....

Announcement relating to the voluntary delisting of Allergan Notes PR Newswire DUBLIN, April 28, 2020 DUBLIN , April 28, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc (NYSE: AGN) (" Allergan ") announced today that it has notified the New York Stock Exchange (" NYSE ") of its intention to voluntarily withdraw...

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for patent applications covering the formulation of the 72 mcg dose of LINZESS® (linaclotide) and methods of using the formulation. The patent applications are expected to issue in 2020 and expire in 2031. LINZESS is approved and marketed in the United States for the treatment of adult men and women suffering from irritable bowel syndrome with...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORMATION Name of person dealing (Note 1) Davidson Kempner Capital Management LP Company dealt in Allergan PLC Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.0001 ordinary shares Date of dealing 2020-04-24 INTERESTS AND SHORT POSITIONS Interests and...

Pentwater Capital Management LP - Form - 8.3 Allergan Plc PR Newswire London, April 27 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...

Pentwater Capital Management LP - Form 8.3 - Allergan Plc PR Newswire London, April 24 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) Pentwater Capital Management LP Company dealt in Allergan Plc Class of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 Ordinary...